{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:06:25Z","timestamp":1779879985750,"version":"3.53.1"},"reference-count":33,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics and Practice"],"abstract":"<jats:p>Background\/Objectives: Metabolic dysfunction-associated steatohepatitis (MASH) is frequently accompanied by disturbances in coagulation and metabolic homeostasis, partly related to impaired handling of vitamin K-dependent pathways. Although vitamin K is often administered to correct abnormal coagulation tests, its biochemical impact in hospitalized patients with MASH remains insufficiently characterized. This study aimed to evaluate changes in coagulation and metabolic parameters in hospitalized patients with MASH receiving vitamin K supplementation. Methods: We conducted a retrospective study of 84 hospitalized MASH patients who received vitamin K supplementation. Biochemical parameters were recorded at admission and discharge to assess short-term changes during hospitalization. Results: Vitamin K supplementation was associated with modest changes in coagulation parameters, including reductions in PT, INR, and aPTT (e.g., PT decreased from 13.00 s to 11.00 s). Small numerical changes in transaminases, fasting glucose, and total cholesterol were observed during hospitalization, with limited clinical relevance. These patterns were comparable across fibrosis stages, with no significant differences between groups. Discussion: The observed biochemical findings are likely in-hospital factors rather than a direct metabolic effect of vitamin K. Conclusions: Vitamin K supplementation was associated with modest changes in coagulation parameters and small, clinically negligible variations in selected metabolic markers in patients with MASH, irrespective of fibrosis stage. These findings suggest a supportive biochemical effect in selected contexts; further prospective studies are needed to clarify their clinical relevance.<\/jats:p>","DOI":"10.3390\/clinpract16050097","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:19:52Z","timestamp":1779877192000},"page":"97","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Changes in Coagulation Parameters and Metabolic Profile in Hospitalized Patients with Metabolic Dysfunction-Associated Steatohepatitis Receiving Vitamin K: A Retrospective Observational Study"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3673-2747","authenticated-orcid":false,"given":"Magdalena","family":"Lixandru","sequence":"first","affiliation":[{"name":"Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 550169 Sibiu, Romania"},{"name":"Sibiu County Emergency Clinical Hospital, 550245 Sibiu, Romania"},{"name":"Valcea County Emergency Hospital, 240284 Valcea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0419-5867","authenticated-orcid":false,"given":"George","family":"Maniu","sequence":"additional","affiliation":[{"name":"Mathematics and Informatics Department, Research Center in Informatics and Information Technology, Faculty of Sciences, \u201cLucian Blaga\u201d University of Sibiu, 550025 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2415-9441","authenticated-orcid":false,"given":"Cosmin Ionut","family":"Lixandru","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 550169 Sibiu, Romania"},{"name":"Sibiu County Emergency Clinical Hospital, 550245 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Grosu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 550169 Sibiu, Romania"},{"name":"Sibiu County Emergency Clinical Hospital, 550245 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: Clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Tana, C., Ballestri, S., Ricci, F., Di Vincenzo, A., Ticinesi, A., Gallina, S., Giamberardino, M.A., Cipollone, F., Sutton, R., and Vettor, R. (2019). Cardiovascular risk in non-alcoholic fatty liver disease: Mechanisms and therapeutic implications. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16173104"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Bucurica, S., Nancoff, A.S., Dutu, M., Mititelu, M.R., Gaman, L.E., Ioni\u021b\u0103-Radu, F., Jinga, M., Maniu, I., and Ru\u021ba, F. (2024). Exploring the Relationship between Lipid Profile, Inflammatory State and 25-OH Vitamin D Serum Levels in Hospitalized Patients. Biomedicines, 12.","DOI":"10.3390\/biomedicines12081686"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ionita-Radu, F., Patoni, C., Nancoff, A.S., Marin, F.-S., Gaman, L., Bucurica, A., Socol, C., Jinga, M., Dutu, M., and Bucurica, S. (2024). Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease\u2014Clinical and Pre-Clinical Overview and Systematic Review of the Literature. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25084201"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1160\/TH08-03-0147","article-title":"Metabolism and cell biology of vitamin K","volume":"100","author":"Shearer","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MBC.0b013e32835975ed","article-title":"The coagulopathy of liver disease: Does vitamin K help?","volume":"24","author":"Saja","year":"2013","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1160\/TH08-02-0087","article-title":"Matrix Gla-protein: The calcification inhibitor in need of vitamin K","volume":"100","author":"Schurgers","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/MPG.0b013e31819a61ff","article-title":"Prevalence of subclinical vitamin K deficiency in cholestatic liver disease","volume":"49","author":"Strople","year":"2009","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1160\/TH07-04-0266","article-title":"Vitamin K: The coagulation vitamin that became omnipotent","volume":"98","author":"Cranenburg","year":"2007","journal-title":"Thromb. Haemost."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2015.04.013","article-title":"Gas6\/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation","volume":"63","author":"Stefanovic","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/aje\/kwm306","article-title":"Vitamin K and vitamin D status: Associations with inflammatory markers in the Framingham Offspring Study","volume":"167","author":"Shea","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wang, X., Zhang, Y., Huang, L., Li, J., and Gao, X. (2023). The relationship between vitamin K and metabolic dysfunction-associated fatty liver disease: A cross-sectional NHANES analysis. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1086477"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sultana, H., Komai, M., and Shirakawa, H. (2021). The role of vitamin K in cholestatic liver disease. Nutrients, 13.","DOI":"10.3390\/nu13082515"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1060028015617277","article-title":"Impact of vitamin K administration on INR changes and bleeding events among patients with cirrhosis","volume":"50","author":"Meyer","year":"2016","journal-title":"Ann. Pharmacother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40560-020-00517-5","article-title":"The effect of vitamin K on prothrombin time in critically ill patients: An observational registry study","volume":"9","author":"Dahlberg","year":"2021","journal-title":"J. Intensive Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"10760296211050923","DOI":"10.1177\/10760296211050923","article-title":"Appropriateness of using vitamin K for the correction of INR elevation secondary to hepatic disease in critically ill patients: An observational study","volume":"27","author":"Aldosary","year":"2021","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2018). EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J. Hepatol., 69, 406\u2013460.","DOI":"10.1016\/j.jhep.2018.08.009"},{"key":"ref_22","unstructured":"Mocan, I. (2005). SPSS Introduction in Data Analysis, Lucian Blaga University Publishing House. (In Romanian)."},{"key":"ref_23","unstructured":"Maniu, I. (2014). Data Analysis Techniques: Statistics, Lucian Blaga University Publishing House. (In Romanian)."},{"key":"ref_24","first-page":"131","article-title":"Routine Use of Vitamin K in the Treatment of Cirrhosis-Related Coagulopathy: Is It A-O-K? Maybe Not, We Say","volume":"44","author":"Aldrich","year":"2019","journal-title":"Pharm. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/gidisord4010003","article-title":"The Role of Vitamin K in Cirrhosis: Do Pharmaco-K-Netics Matter?","volume":"4","author":"Jin","year":"2022","journal-title":"Gastrointest. Disord."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Robuck PR Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e19554","DOI":"10.1097\/MD.0000000000019619","article-title":"Effect of Vitamin K1 on Survival of Patients with Chronic Liver Failure: A Retrospective Cohort Study","volume":"99","author":"Xiong","year":"2020","journal-title":"Medicine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1038\/s41598-024-53644-6","article-title":"Vitamin K2 Protects Mice Against Non-Alcoholic Fatty Liver Disease Induced by High-Fat Diet","volume":"14","author":"Zhao","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"19272","DOI":"10.1038\/s41598-025-03258-3","article-title":"Dietary Vitamin K Intake Associates with Reduced All-Cause Mortality in Non-Alcoholic Fatty Liver Disease Patients","volume":"15","author":"Huang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1007\/s00394-023-03215-8","article-title":"The Effect of Vitamin K4 Supplementation on Insulin Resistance in Individuals with Type 2 Diabetes: A Double-Blind Randomised Placebo-Controlled Clinical Trial","volume":"62","author":"Ali","year":"2023","journal-title":"Eur. J. Nutr."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Liu, L., Wei, C., Wang, X., Li, R., Xu, X., Zhang, Y., Geng, G., Dang, K., and Ming, Z. (2023). Vitamin K2 Supplementation Improves Impaired Glycemic Homeostasis and Insulin Sensitivity in Type 2 Diabetes Through Gut Microbiome and Fecal Metabolites. BMC Med., 21.","DOI":"10.1186\/s12916-023-02880-0"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"101491","DOI":"10.1016\/j.aohep.2024.101491","article-title":"Dietary Macro and Micronutrients Associated with MASLD: Analysis of a National US Cohort Database","volume":"29","author":"Nemer","year":"2024","journal-title":"Ann. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13054-024-05001-2","article-title":"Vitamin K: A potential missing link in critical illness\u2014A scoping review","volume":"28","author":"Paulus","year":"2024","journal-title":"Crit. Care"}],"container-title":["Clinics and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2039-7283\/16\/5\/97\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:35:05Z","timestamp":1779878105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-7283\/16\/5\/97"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["clinpract16050097"],"URL":"https:\/\/doi.org\/10.3390\/clinpract16050097","relation":{},"ISSN":["2039-7283"],"issn-type":[{"value":"2039-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]}}}